Kimia Biosciences Approves FY26 Audited Results

Kimia Biosciences Ltd. approved its audited standalone financial results for the financial year ended March 31, 2026, during a board meeting held on May 29, 2026. The results, along with the Independent Auditor’s Report, were reviewed and taken on record by the Board of Directors. The meeting commenced at 3:55 p.m. and concluded at 4:35 p.m. The auditor's report indicates a true and fair view of the company's state of affairs, profit, other comprehensive income, changes in equity, and cash flows for the specified period.